使用审查数据的平均成本和成本效益比:一个教程和SAS®宏
Eduard Poltavskiy1, Dingning Liu2, Shuai Chen2,3,4
1Independent researcher, Sacramento, CA, USA.
Biostatistics & epidemiology
|December 5, 2025
概括
审查是医疗成本和生存数据分析的关键挑战. 本教程解释了如何使用审查数据估计平均成本和成本效益比率,并提供了实际的SAS代码示例.
科学领域:
- 卫生经济学 卫生经济学
- 生物统计学 生物统计学
- 生存分析的分析.
背景情况:
- 审查是分析医疗成本和生存数据的一个重大挑战.
- 医疗费用可以被视为生存数据,积累到死亡等终点.
- 自1997年和1998年的里程碑性论文以来,审查成本数据已被广泛研究.
研究的目的:
- 为提供一个教程,以审查数据估计平均成本和成本效益比率.
- 解决两个常见的数据场景:总成本数据和纵向成本历史.
- 提供关于审查成本数据分析的最新文献评论.
主要方法:
- 用审查数据估计平均成本的方法的解释.
- 在存在审查的情况下计算成本效益比率的指导.
- 使用总成本和纵向成本数据的说明性示例.
主要成果:
- 对被审查数据的成本和成本效益估计技术的演示.
- 不同数据结构的实际应用示例.
- 为从业人员和数据分析师提供SAS代码.
结论:
- 准确估计医疗成本和成本效益是可行的,尽管数据审查.
- 该教程为研究人员分析医疗保健成本提供了有价值的方法和工具.
- 更新的文献审查和实用的SAS代码增强了数据分析师的实用性.
相关概念视频
Censoring Survival Data
505
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
505
Comparing the Survival Analysis of Two or More Groups
538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Statistical Analysis System (SAS)
796
SAS, short for Statistical Analysis System, is a powerful data analysis, management, and visualization tool. Developed by the SAS Institute in the early 1970s, SAS has evolved into a comprehensive software suite used across various industries for statistical analysis, business intelligence, and predictive modeling.
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...
796
Kaplan-Meier Approach
537
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
537
Introduction To Survival Analysis
714
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
714
Assumptions of Survival Analysis
385
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
385


